Empirical Wealth Management’s Cognition Therapeutics CGTX Stock Holding History
Bought
Maintained
Sold
Other funds holding CGTX
C
CM
Empirical Wealth Management's CGTX Position: Q3 2026 in Review
Empirical Wealth Management held its Cognition Therapeutics (CGTX) position steady in Q3 2026 at 48,000 shares worth $46.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1145.
Empirical Wealth Management first reported a position in CGTX in Q2 2025 and has held it in 6 quarters since. The position peaked at $64.8K in Q4 2025. 78 funds tracked by Wall St. Rank hold CGTX as of Q3 2026.
- Empirical Wealth Management held 48,000 shares of Cognition Therapeutics worth $46.1K as of Q3 2026.
- Empirical Wealth Management left its Cognition Therapeutics share count unchanged in Q3 2026.
- Cognition Therapeutics made up ﹤0.01% of Empirical Wealth Management's portfolio in Q3 2026, its #1145 holding.
- Empirical Wealth Management first reported a position in Cognition Therapeutics in Q2 2025 and has held it in 6 quarters since.
- Empirical Wealth Management's Cognition Therapeutics position peaked at $64.8K in Q4 2025.
- 78 funds tracked by Wall St. Rank held Cognition Therapeutics as of Q3 2026.
Based on Empirical Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.